Efficacy of MASPORT in Blepharospasm
Phase 3
Recruiting
- Conditions
- Benign Essential Blepharospasm (BEB).BlepharospasmG24.5
- Registration Number
- IRCT20240216061023N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 19
Inclusion Criteria
Clinically diagnosed with BEB
Without prior BTX-A injection in the previous 6 month
History of previous eyelid surgery
Exclusion Criteria
pregnancy or lactation
secondary causes of Blepharospasm
History of disorders of the neuromuscular junction like myasthenia gravis, Eaton-Lambert Syndrome, and psychological instability
prescription of antispastic, muscle relaxants or medications affecting neuromuscular junction transmission such as aminoglycosides
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Advance in the severity and frequency grades of spasms (more than at least one grade improvement in severity score. Timepoint: Four weeks post-injection phase. Method of measurement: Based on Severity and Frequency Spasm Score.
- Secondary Outcome Measures
Name Time Method